Kymera Therapeutics (NASDAQ:KYMR) Hits New 52-Week Low on Disappointing Earnings
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report)’s share price reached a new 52-week low on Friday after the company announced weaker than expected quarterly earnings. The company traded as low as $29.22 and last traded at $29.98, with a volume of 1722609 shares. The stock had previously closed at $35.36. The company reported ($0.88) […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report)’s share price reached a new 52-week low on Friday after the company announced weaker than expected quarterly earnings. The company traded as low as $29.22 and last traded at $29.98, with a volume of 1722609 shares. The stock had previously closed at $35.36. The company reported ($0.88) […]
